Cleared Traditional

K972535 - MAGLIFE C

K972535 is the FDA 510(k) clearance for MAGLIFE C by Odam. It is a Class 2 Cardiovascular device (product code MHX) cleared through the Traditional 510(k) pathway after a 189-day FDA review.

K972535 · Odam · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1998
Decision
189d
Days
Class 2
Risk

K972535 is an FDA 510(k) clearance for the MAGLIFE C. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Odam (North Attleboro, US). The FDA issued a Cleared decision on January 13, 1998 after a review of 189 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Odam devices

Submission Details

510(k) Number K972535 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 08, 1997
Decision Date January 13, 1998
Days to Decision 189 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
64d slower than avg
Panel avg: 125d · This submission: 189d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 303
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K972535.
SPACELABS MEDICAL ULTRAVIEW DIGITAL TELEMTRY SYSTEM
K983996 · Spacelabs Medical, Inc. · Jun 1999
SIEMENS SC 8000 BEDSIDE MONITOR WITH ADVANCED COMMUNICATION OPTION
K990563 · Siemens Medical Solutions USA, Inc. · Mar 1999
NPB3900 SERIES PATIENT MONITORS
K980411 · Analogic Corp. · Aug 1998
DINAMAP COMPACT MONITOR
K970182 · Johnson & Johnson Medical, Inc. · Aug 1997
NPB-4000
K962424 · Analogic Corp. · Dec 1996
DINAMAP VITAL SIGNS MONITOR MODELS 9300 AND 9320/9340
K942700 · Critikon Company, LLC · Mar 1995